• 1
    Young GP, Macrae FA, St John DJB. Clinical methods of early detection: basis, use and evaluation. In: YoungGP, RozenP, LevinB, editors. Prevention and Early Detection of Colorectal Cancer. London: Saunders; 1996: 241270.
  • 2
    Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale—update based on new evidence. Gastroenterology. 2003; 124: 544560.
  • 3
    Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993; 328: 13651371.
  • 4
    Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal occult blood screening for colorectal cancer. Lancet. 1996; 348: 14721477.
  • 5
    Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal occult blood test. Lancet. 1996; 348: 14671471.
  • 6
    Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000; 343: 16031607.
  • 7
    Watson JMG, Jungner G. Principles and Practice of Screening for Disease. World Health Organization Public Health Paper 34; 1968.
  • 8
    Allison JE. Screening for colorectal cancer 2003: Is there still a role for the FOBT? Tech Gastrointest Endosc. 2003; 5: 127133.
  • 9
    Podolsky DK. Going the distance – The case for true colorectal cancer screening. N Engl J Med. 2000; 343: 207208.
  • 10
    Detsky AS. Screening for colon cancer – Can we afford colonoscopy? N Engl J Med. 2001; 345: 607608.
  • 11
    Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A. Colorectal cancer prevention 2000: Screening recommendations of the American College of Gastroenterology. Am J Gastroenterol. 2000; 95: 868877.
  • 12
    Lieberman DA, Weiss DG; Veterans Affairs Cooperative Study Group 380. One time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med. 2001; 345: 555560.
  • 13
    Allison JE, Tekewa JS, Ransom LJ, Adrian AL. A comparison of fecal occult blood tests for colorectal cancer screening. N Engl J Med. 1996: 334: 144159.
  • 14
    Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med. 2004; 351: 27042714.
  • 15
    Petty MT, Deacon MC, Alexeyeff MA, St John DJ, Young GP. Readability and sensitivity of a new faecal occult blood test in a hospital ward environment. Med J Aust. 1992; 156: 420423.
  • 16
    Young GP, Rozen P, Levin B. How should we screen for early colorectal neoplasia. In: RozenP, YoungGP, LevinB, SpannSJ, editors. Colorectal Cancer in Clinical Practice. London: Martin Dunitz; 2002. p. 7799.
  • 17
    Allison JE, Fledman R, Tekawa I. Hemoccult screening in detecting colorectal neoplasms: sensitivity, specificity and predictive value. Ann Intern Med. 1999; 112: 328333.
  • 18
    Feinberg EJ, Steinberg WM, Banks BL, Henry JP. How long to abstain from eating red meat before fecal occult blood tests. Ann Intern Med. 1990; 113: 403404.
  • 19
    Lynch NM, McHutchison JG, Young GP, Deacon M, St John DJB, Barraclough D. Gastrointestinal blood loss from a new buffered aspirin (Ostoprin): Measurement by radiochromium and HemoQuant™ techniques. Aust NZ J Med. 1989; 19: 8996.
  • 20
    Cole SR, Young GP. Effect of dietary restriction on participation in faecal occult blood test screening for colorectal cancer. Med J Aust. 2001; 175: 195198.
  • 21
    Young GP, St John DJB. Faecal occult blood tests, choice, usage and clinical applications. Clin Biochem Rev. 1992; 13: 161167.
  • 22
    Ahlquist DA, Schwartz S, Isaacson J, Ellefson M. A stool collection device: the first step in occult blood testing. Ann Intern Med. 1988; 108: 609612.
  • 23
    Young GP, St John DJB, Cole SR, et al. A prescreening evaluation of a brush-based faecal immunochemical test for haemoglobin. J Med Screening. 2003; 10: 123128.
  • 24
    Cole SR, Young GP, Esterman A, Cadd B, Morcom J. A randomized trial of the impact of new fecal hemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screening. 2003; 10: 117122.
  • 25
    Young GP. Screening for colorectal cancer: Alternative fecal occult blood tests. Eur J Gastroenterol Hepatol. 1998; 10: 205212.
  • 26
    Bampton PA, Sandford JJ, Cole SR, et al. Interval Faecal Occult Blood Testing in a Colonoscopy Based Screening Program Detects Additional Pathology. Gut. 2005; 54: 803806.
  • 27
    NHMRC. Guidelines for the prevention, early detection and management of colorectal cancer. Canberra: NHMRC; 1992: Chapter 3.
  • 28
    St John DJB, Young GP, Alexeyeff MA, et al. Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology. 1993; 104: 16611668.
  • 29
    Gardner MJ, Altman DG. Confidence intervals rather than P values: estimation rather than hypothesis testing. BMJ. 1986; 292: 746750.
  • 30
    Fielding LP. Staging Systems. In: CohenAM, WinawerSJ, FriedmanMA, GyndersonLJ, editors. Cancer of the colon, rectum and anus. New York: McGraw-Hill, 1995: 207215.
  • 31
    Woolf SH: The best screening test for colorectal cancer – A personal choice. N Engl J Med. 2000; 343: 16411643.
  • 32
    Fletcher RH: Screening colonoscopy: Option or preference? Gastrointest Endosc. 2000; 51: 624627.
  • 33
    Young GP, St John DJB, Winawer SJ, Rozen P. Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies. Am J Gastroenterol. 2002; 97: 24992507.
  • 34
    Wong BCY, Wong WM, Cheung KL, et al. A Sensitive Guaiac Fecal Occult Blood Test is Less Useful than an Immunochemical Test for Colorectal Cancer Screening in a Chinese Population. Alim Pharmacol Therap. 2003; 18: 941946.